Analyst Ranking
Top 4%
#189 out of 5561 analysts
Average Return
+18.36%
Win Rate
64%110 out of 172
Risk vs Reward
Poor
Good

David Amsellem's 5 best and worst ratings

Name / TickerGain/LossEntry PriceExit PricePeriodRating
Supernus IncSUPN
+224.06%$9.89$32.05
2025-03-06 -
2026-03-05
Strong Buy
Amneal Pharmaceuticals IncAMRX
+222.28%$2.02$6.51
2023-05-08 -
2024-05-07
Strong Buy
Supernus IncSUPN
+218.77%$7.46$23.78
2024-10-11 -
2025-10-10
Strong Buy
Horizon Therapeutics Public Ltd CoHZNP
+189.77%$31.56$91.45
2020-04-14 -
2021-04-14
Strong Buy
Supernus IncSUPN
+179.22%$9.00$25.13
2024-10-25 -
2025-10-24
Strong Buy

David Amsellem Analyst Color

Get additional color on David Amsellem's coverage of popular stocks

David Amsellem's Stock Coverage

Name / TickerNo. RatingsRatingPrice TargetUpside/DownsideActionDate
Pelthos Therapeutics IncPTHS
2Strong Buy$21.00+193.71%Reiterates
4 days ago
Teva Pharmaceutical Industries LtdTEVA
12Strong Buy$56.00+31.55%Maintains
5 days ago
Jazz Pharmaceuticals PLCJAZZ
14Strong Buy$330.00+37.63%Maintains
5 days ago
Biogen IncBIIB
8Strong Buy$305.00+21.20%Reiterates
8 days ago
Xeris Biopharma Holdings IncXERS
7Hold$12.00-28.14%Reiterates
11 days ago
Collegium Pharmaceutical IncCOLL
9Hold$28.00+10.11%Maintains
11 days ago
Supernus Pharmaceuticals IncSUPN1
13Strong Buy$47.00+79.66%Reinstates
13 days ago
Corcept Therapeutics IncCORT
11Strong Buy$173.00+149.93%Reiterates
13 days ago
Neurocrine Biosciences IncNBIX
12Strong Buy$215.00+30.06%Maintains
14 days ago
Viatris IncVTRS
10Hold$14.00-32.50%Maintains
22 days ago
Bristol Myers Squibb CoBMY
5Strong Buy$78.00+23.95%Maintains
22 days ago
Axsome Therapeutics IncAXSM
6Strong Buy$238.00+73.71%Maintains
22 days ago
Amgen IncAMGN
9Strong Buy$457.00-1.15%Maintains
3 months ago
Abbvie IncABBV
8Strong Buy$303.00+2.87%Maintains
3 months ago
Definium Therapeutics IncDFTX
4Strong Buy$75.00+148.67%Reiterates
3 months ago
Amphastar Pharmaceuticals IncAMPH
10Hold$20.00-31.44%Maintains
3 months ago
Alkermes PLCALKS
10Strong Buy$65.00+39.69%Reiterates
4 months ago
Organon & CoOGN
7Hold$14.00+0.72%Upgrades
7 months ago
Fennec Pharmaceuticals IncFENC
1Strong Buy$18.00+41.07%Initiates Coverage On
10 months ago
Esperion Therapeutics IncESPR
1Strong Buy$9.00+183.02%Initiates Coverage On
a year ago
Aquestive Therapeutics IncAQST
2Strong Buy$8.00N/AMaintains
a year ago
Supernus IncSUPN
6Strong Buy$41.00N/AReiterates
a year ago
Amneal Pharmaceuticals IncAMRX
5Strong Buy$13.00N/AReiterates
a year ago
Sage Therapeutics IncSAGE
2Hold$8.50N/ADowngrades
a year ago
Optinose IncOPTN
3Hold$9.00N/ADowngrades
2 years ago
Intra Cellular Therapies IncITCI
1Hold$132.00N/ADowngrades
2 years ago
Avadel Pharmaceuticals PLCAVDL
4Strong Buy$13.00N/AMaintains
2 years ago
Ani Pharmaceuticals IncANIP
1Strong Buy$68.00N/AInitiates Coverage On
2 years ago
Revance Therapeutics IncRVNC
7Strong Buy$6.00N/AMaintains
2 years ago
Bausch Health Companies IncBHC
4Strong Sell$3.00N/ADowngrades
2 years ago
Pacira Biosciences IncPCRX
7Strong Buy$42.00N/AMaintains
2 years ago
Ironwood Pharmaceuticals IncIRWD
3Strong Buy$21.00N/AMaintains
3 years ago
Cerevel Therapeutics Holdings IncCERE
2Hold$45.00N/ADowngrades
3 years ago
Tvardi Therapeutics IncTVRD
3Hold$12.00N/ADowngrades
3 years ago
Harmony Biosciences Holdings IncHRMY
3Strong Buy$42.00N/AMaintains
3 years ago
Eagle Pharmaceuticals IncEGRX
2Strong Sell$17.00N/ADowngrades
3 years ago
Karuna Therapeutics IncKRTX
1Strong Buy$285.00N/AInitiates Coverage On
4 years ago
Horizon Therapeutics Public Ltd CoHZNP
3Strong Buy$110.00N/AMaintains
4 years ago
Antares Pharma IncATRS
1Hold$5.60N/ADowngrades
5 years ago
Endo International PLCENDPQ
3Hold$3.00N/AMaintains
5 years ago
Biodelivery Sciences International IncBDSI
1Hold$5.60N/ADowngrades
5 years ago
Adamas Pharmaceuticals IncADMS
1Hold$8.00N/ADowngrades
5 years ago
Evofem Biosciences IncEVFM
1Strong Buy$165.00N/AInitiates Coverage On
6 years ago
Impax Laboratories IncIPXL
1HoldN/AN/AUpgrades
9 years ago
Societal Cdmo IncSCTL
1Strong Buy$12.00N/AInitiates Coverage On
10 years ago
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.